A viral assembly inhibitor blocks SARS-CoV-2 replication in airway epithelial cells
Inhibition of mRNA nuclear export promotes SARS-CoV-2 pathogenesis
SARS-CoV-2 Inhibitors Identified by Phenotypic Analysis of a Collection of Viral RNA-Binding Molecules
Protocol for production and purification of SARS-CoV-2 3CLpro
Structural similarities between SARS-CoV2 3CLpro and other viral proteases suggest potential lead molecules for developing broad spectrum antivirals
Ancestral, Delta, and Omicron (BA.1) SARS-CoV-2 strains are dependent on serine proteases for entry throughout the human respiratory tract
Parallel use of human stem cell lung and heart models provide insights for SARS-CoV-2 treatment
Identification of In Vitro Inhibitors of Monkeypox Replication
Inhibition of SARS-CoV-2 growth in the lungs of mice by a peptide-conjugated morpholino oligomer targeting viral RNA
Register for our 2nd Annual Symposium on March 27, 2024 - La Jolla, CA
Pandemic Preparedness Symposium - March 8, 2023
COVID-19: Progress and Lessons Learned
Advancing Respiratory Virus Therapeutics: Lessons Learned from COVID-19
CIDD Annual Drug Discovery Symposium
Leading minds on COVID-19 come together for Pandemic Preparedness Symposium- Scripps Research
Congrats to our collaborator Dr. Disney
It's time to register for our Symposium on March 8, 2023 in La Jolla, California
Congratulations to our collaborator Dr. Stefano Forli for his award!
Targeted protein S-nitrosylation of ACE2 inhibits SARS-CoV-2 infection
SARS-CoV-2 Inhibitors Identified by Phenotypic Analysis Collection of Viral RNA-Binding Molecules